508 related articles for article (PubMed ID: 25484286)
1. Blocking GSK3β-mediated dynamin1 phosphorylation enhances BDNF-dependent TrkB endocytosis and the protective effects of BDNF in neuronal and mouse models of Alzheimer's disease.
Liu XH; Geng Z; Yan J; Li T; Chen Q; Zhang QY; Chen ZY
Neurobiol Dis; 2015 Feb; 74():377-91. PubMed ID: 25484286
[TBL] [Abstract][Full Text] [Related]
2. Running exercise delays neurodegeneration in amygdala and hippocampus of Alzheimer's disease (APP/PS1) transgenic mice.
Lin TW; Shih YH; Chen SJ; Lien CH; Chang CY; Huang TY; Chen SH; Jen CJ; Kuo YM
Neurobiol Learn Mem; 2015 Feb; 118():189-97. PubMed ID: 25543023
[TBL] [Abstract][Full Text] [Related]
3. Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice.
Dobarro M; Gerenu G; Ramírez MJ
Int J Neuropsychopharmacol; 2013 Nov; 16(10):2245-57. PubMed ID: 23768694
[TBL] [Abstract][Full Text] [Related]
4. The novel squamosamide derivative FLZ enhances BDNF/TrkB/CREB signaling and inhibits neuronal apoptosis in APP/PS1 mice.
Li N; Liu GT
Acta Pharmacol Sin; 2010 Mar; 31(3):265-72. PubMed ID: 20154710
[TBL] [Abstract][Full Text] [Related]
5. SCM-198 Ameliorates Cognitive Deficits, Promotes Neuronal Survival and Enhances CREB/BDNF/TrkB Signaling without Affecting Aβ Burden in AβPP/PS1 Mice.
Hong ZY; Yu SS; Wang ZJ; Zhu YZ
Int J Mol Sci; 2015 Aug; 16(8):18544-63. PubMed ID: 26262618
[TBL] [Abstract][Full Text] [Related]
6. Opposing effects of APP/PS1 and TrkB.T1 genotypes on midbrain dopamine neurons and stimulated dopamine release in vivo.
Kärkkäinen E; Yavich L; Miettinen PO; Tanila H
Brain Res; 2015 Oct; 1622():452-65. PubMed ID: 26168899
[TBL] [Abstract][Full Text] [Related]
7. Amyloid beta selectively modulates neuronal TrkB alternative transcript expression with implications for Alzheimer's disease.
Wong J; Higgins M; Halliday G; Garner B
Neuroscience; 2012 May; 210():363-74. PubMed ID: 22426239
[TBL] [Abstract][Full Text] [Related]
8. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K
Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994
[TBL] [Abstract][Full Text] [Related]
9. TrkB reduction exacerbates Alzheimer's disease-like signaling aberrations and memory deficits without affecting β-amyloidosis in 5XFAD mice.
Devi L; Ohno M
Transl Psychiatry; 2015 May; 5(5):e562. PubMed ID: 25942043
[TBL] [Abstract][Full Text] [Related]
10. Roles of brain-derived neurotrophic factor/tropomyosin-related kinase B (BDNF/TrkB) signalling in Alzheimer's disease.
Zhang F; Kang Z; Li W; Xiao Z; Zhou X
J Clin Neurosci; 2012 Jul; 19(7):946-9. PubMed ID: 22613489
[TBL] [Abstract][Full Text] [Related]
11. Donepezil improves the cognitive impairment in a tree shrew model of Alzheimer's disease induced by amyloid-β
Zheng H; Niu S; Zhao H; Li S; Jiao J
Metab Brain Dis; 2018 Dec; 33(6):1961-1974. PubMed ID: 30105614
[TBL] [Abstract][Full Text] [Related]
12. Delta-secretase-cleaved Tau antagonizes TrkB neurotrophic signalings, mediating Alzheimer's disease pathologies.
Xiang J; Wang ZH; Ahn EH; Liu X; Yu SP; Manfredsson FP; Sandoval IM; Ju G; Wu S; Ye K
Proc Natl Acad Sci U S A; 2019 Apr; 116(18):9094-9102. PubMed ID: 31004063
[TBL] [Abstract][Full Text] [Related]
13. HO-1 attenuates hippocampal neurons injury via the activation of BDNF-TrkB-PI3K/Akt signaling pathway in stroke.
Qi D; Ouyang C; Wang Y; Zhang S; Ma X; Song Y; Yu H; Tang J; Fu W; Sheng L; Yang L; Wang M; Zhang W; Miao L; Li T; Huang X; Dong H
Brain Res; 2014 Aug; 1577():69-76. PubMed ID: 24997248
[TBL] [Abstract][Full Text] [Related]
14. Myosin Va mediates BDNF-induced postendocytic recycling of full-length TrkB and its translocation into dendritic spines.
Sui WH; Huang SH; Wang J; Chen Q; Liu T; Chen ZY
J Cell Sci; 2015 Mar; 128(6):1108-22. PubMed ID: 25632160
[TBL] [Abstract][Full Text] [Related]
15. Blockage of GSK3β-mediated Drp1 phosphorylation provides neuroprotection in neuronal and mouse models of Alzheimer's disease.
Yan J; Liu XH; Han MZ; Wang YM; Sun XL; Yu N; Li T; Su B; Chen ZY
Neurobiol Aging; 2015 Jan; 36(1):211-27. PubMed ID: 25192600
[TBL] [Abstract][Full Text] [Related]
16. Clathrin-dependent endocytosis is required for TrkB-dependent Akt-mediated neuronal protection and dendritic growth.
Zheng J; Shen WH; Lu TJ; Zhou Y; Chen Q; Wang Z; Xiang T; Zhu YC; Zhang C; Duan S; Xiong ZQ
J Biol Chem; 2008 May; 283(19):13280-8. PubMed ID: 18353779
[TBL] [Abstract][Full Text] [Related]
17. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
[TBL] [Abstract][Full Text] [Related]
18. TrkB activation by 7, 8-dihydroxyflavone increases synapse AMPA subunits and ameliorates spatial memory deficits in a mouse model of Alzheimer's disease.
Gao L; Tian M; Zhao HY; Xu QQ; Huang YM; Si QC; Tian Q; Wu QM; Hu XM; Sun LB; McClintock SM; Zeng Y
J Neurochem; 2016 Feb; 136(3):620-36. PubMed ID: 26577931
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic effects of sporoderm-removed Ganoderma lucidum spores in a rat model of streptozotocin-induced sporadic Alzheimer's disease.
Zhao HL; Cui SY; Qin Y; Liu YT; Cui XY; Hu X; Kurban N; Li MY; Li ZH; Xu J; Zhang YH
J Ethnopharmacol; 2021 Apr; 269():113725. PubMed ID: 33352241
[TBL] [Abstract][Full Text] [Related]
20. 7,8-dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease.
Devi L; Ohno M
Neuropsychopharmacology; 2012 Jan; 37(2):434-44. PubMed ID: 21900882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
